Shares of Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) traded down 5.2% on Thursday . The stock traded as low as $4.33 and last traded at $4.42. 632,491 shares traded hands during mid-day trading, a decline of 28% from the average session volume of 875,832 shares. The stock had previously closed at $4.66.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on ACB. TD Cowen assumed coverage on shares of Aurora Cannabis in a report on Wednesday, December 11th. They set a “buy” rating on the stock. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Stock Report on ACB
Aurora Cannabis Trading Down 5.2 %
Institutional Trading of Aurora Cannabis
Large investors have recently bought and sold shares of the company. Tidal Investments LLC lifted its stake in shares of Aurora Cannabis by 2.7% during the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after buying an additional 34,988 shares in the last quarter. Headlands Technologies LLC lifted its position in shares of Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after acquiring an additional 37,269 shares in the last quarter. TD Asset Management Inc purchased a new stake in shares of Aurora Cannabis during the second quarter worth $255,000. Mackenzie Financial Corp bought a new position in shares of Aurora Cannabis in the second quarter worth $113,000. Finally, Toronto Dominion Bank grew its position in shares of Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares in the last quarter. 47.63% of the stock is owned by hedge funds and other institutional investors.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
- Five stocks we like better than Aurora Cannabis
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Profitably Trade Stocks at 52-Week Highs
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is an Earnings Surprise?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.